Linezolid to Decrease Length of Stay in the Hospital for Patients with Methicillin- Resistant Staphylococcus aureus Infection

January 2003
Clinical Infectious Diseases;1/1/2003, Vol. 36 Issue 1, p124
Academic Journal
No abstract available.


Related Articles

  • Linezolid leverages shorter lengths of stay. Prescott, Lawrence M. // Dermatology Times;Dec2000, Vol. 21 Issue 12, p46 

    Reports on the efficacy of antibiotic linezolid in shortening the hospital stays for patients with difficult-to-treat skin and soft tissue infections in the United States. Cost-effectiveness comparison of treating methicillin resistant Staphylococcus aureus (MRSA) infections versus non-MRSA...

  • Response to Emerging Infection Leading to Outbreak of Linezolid-Resistant Enterococci. Kainer, Marion A.; Devasia, Rose A.; Jones, Timothy F.; Simmons, Bryan P.; Melton, Kelley; Chow, Susan; Broyles, Joyce; Moore, Kelly L.; Craig, Allen S.; Schaffner, William // Emerging Infectious Diseases;Jul2007, Vol. 13 Issue 7, p1024 

    Linezolid was approved in 2000 for treatment of gram-positive coccal infections. We performed a case-control study during a hospital outbreak of linezolid-resistant enterococci (LRE) infections, comparing cases of LRE infection (cases) with linezolid-sensitive enterococci infections (controls)....

  • Alternatives for MRSA Treatment in the Pediatric Patient. Lopez, Ibis D. // Orthopedics;Oct2004, Vol. 27 Issue 10, p1051 

    The article offers alternatives for methicillin resistant Staphylococcus aureus treatment in the pediatric patient. One alternative is vancomycin. The effectiveness of the drug is assessed. Moreover, this article discusses the safety of linezolid in treating Staphylococcus aureus infections.

  • Community hospitals often fail to treat MRSA adequately. Volansky, Rob // Infectious Disease News;Jun2008, Vol. 21 Issue 6, p16 

    The article reports on the results on the antimicrobial treatment received by patients with methicillin-resistant Staphylococcus aureus infections at hospitals in Virginia and North Carolina. Treatments administered included vancomycin, ciprofloxacin and linezolid. A total of 377 patients have...

  • Health Care--Associated Infection Prevention and Control: Pharmacists' Role in Meeting National Patient Safety Goal 7. Tauman, Allison V.; Robicsek, Ari; Roberson, Joyce; Boyce, John M.; Wachter, Robert M.; Rich, Darryl S. // Hospital Pharmacy;May2009, Vol. 44 Issue 5, p401 

    Health care-associated infections and antimicrobial resistance are continually increasing, with fewer drugs available for effective treatment. Potential benefits of infection control and antimicrobial stewardship programs include improvements in antibiotic use and conversion from intravenous...

  • Single-Patient ICU Rooms Decrease Infection Acquisition.  // Pulmonary Reviews;Feb2011, Vol. 16 Issue 2, p21 

    The article reports that intensive care unit (ICU) single rooms can help in isolating and reducing the spread of hospital infections. Researchers from the McGill University Health Center (MUHC) in Montreal, Canada found that the rate of infection acquisition declined by 50 percent for dangerous...

  • Retrospective Analysis of Clinical and Cost Outcomes Associated with Methicillin-Resistant Staphylococcus aureus Complicated Skin and Skin Structure Infections Treated with Daptomycin, Vancomycin, or Linezolid. Wright, Bradley M.; Eiland III, Edward H. // Journal of Pathogens;2011, p1 

    Objective. The objective of this analysis was to compare clinical and cost outcomes associated with patients who had suspected or documented methicillin-resistant Staphylococcus aureus (MRSA) infections treated with daptomycin, vancomycin, or linezolid in complicated skin and skin structure...

  • Linezolid.  // Reactions Weekly;3/26/2011, Issue 1344, p21 

    The article describes cases of thrombocytopenia and anaemia in three elderly patients who had renal dysfunction during intravenous linezolid therapy for methicillin-resistant Staphylococcus aureus infection.

  • Penn Researchers Identify Cost-Effective Antibiotic Treatment Which Shortens Patient Stays.  // Ascribe Newswire: Medicine;2/28/2001, p14 

    The article reports that University of Pennsylvania Health System researchers Henry A. Glick and colleagues have concluded that the antibiotic linezolid has the potential to provide hospitals cost-saving benefits, when used to treat infections resistant to most other antibiotics that can extend...

  • Cost-effectiveness of linezolid versus vancomycin for hospitalised patients with complicated skin and soft-tissue infections in Germany. Schürmann, Dirk; Sorensen, Sonja; Cock, Erwin; Duttagupta, Sandeep; Resch, Ansgar // European Journal of Health Economics;Mar2009, Vol. 10 Issue 1, p65 

    This study used a decision analytic model approach to evaluate the cost-effectiveness of linezolid versus vancomycin in the empirical treatment of complicated skin and soft-tissue infection (cSSTI) due to suspected methicillin-resistant Staphylococcus aureus (MRSA) from the German hospital and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics